American National Registered Investment Advisor Inc. continued to hold its position in Monsanto Company (NYSE:MON) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,533 shares of the basic materials company’s stock at the end of the second quarter. American National Registered Investment Advisor Inc.’s holdings in Monsanto were worth $537,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of MON. BlackRock Inc. boosted its position in Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after buying an additional 25,140,936 shares during the last quarter. York Capital Management Global Advisors LLC boosted its position in Monsanto by 58.4% in the first quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock worth $462,662,000 after buying an additional 1,506,057 shares during the last quarter. Flossbach Von Storch AG boosted its position in Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock worth $462,920,000 after buying an additional 1,034,400 shares during the last quarter. UBS Asset Management Americas Inc. boosted its position in Monsanto by 55.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,181,090 shares of the basic materials company’s stock worth $246,899,000 after buying an additional 775,520 shares during the last quarter. Finally, MARSHALL WACE ASIA Ltd acquired a new position in Monsanto during the first quarter worth about $63,977,000. Hedge funds and other institutional investors own 75.31% of the company’s stock.
Shares of Monsanto Company (MON) traded down 0.33% on Friday, reaching $116.55. The company’s stock had a trading volume of 1,012,471 shares. The company has a market cap of $51.20 billion, a price-to-earnings ratio of 25.17 and a beta of 1.07. The stock has a 50-day moving average of $117.47 and a 200 day moving average of $115.08. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $118.97.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. During the same quarter in the previous year, the business earned $2.17 earnings per share. The company’s revenue was up 1.0% on a year-over-year basis. On average, equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.85%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio is currently 46.75%.
A number of equities analysts have recently weighed in on the company. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a research report on Friday, June 16th. BidaskClub lowered Monsanto from a “hold” rating to a “sell” rating in a research report on Sunday, July 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a research report on Thursday, July 6th. Susquehanna Bancshares Inc reaffirmed a “neutral” rating and set a $128.00 target price (up from $125.00) on shares of Monsanto in a research report on Tuesday, June 27th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $128.00 target price (up from $120.00) on shares of Monsanto in a research report on Thursday, June 29th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $123.15.
In other news, SVP Janet M. Holloway sold 3,337 shares of the business’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the completion of the transaction, the senior vice president now owns 44,405 shares in the company, valued at $5,239,790. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. Insiders sold 74,470 shares of company stock valued at $8,791,281 in the last 90 days. Company insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.